Skip to content
Corcept logo Corcept logo
Main Menu
  • Contact Us
  • About
    • About Corcept
    • Executive Team
    • Board of Directors
    • Educational Grants
    • Contact Us
  • Product
    • Korlym® for Cushing Syndrome
    • Medical Information Request
  • Patients
  • Research & Pipeline
    • Cortisol Modulation
    • Cortisol Modulation Therapeutic Platform
    • Pipeline and Clinical Trials
    • Publications
    • Investigator-Initiated Studies
    • Compassionate Use
  • Investors
    • Investors Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Careers
    • Working at Corcept
    • Benefits
    • Testimonials
    • Current Opportunities
Patient riding a bike

Korlym® (mifepristone)
300 mg Tablets

Korlym Logo Mifepristone
  • Korlym Prescribing Information, including BOXED WARNING
  • Korlym Medication Guide
  • Visit Korlym.com

View information about the Corcept Access & Financial Support and Patient Advocate Program for Korlym.

  • About
    • Executive Team
    • Board of Directors
    • Educational Grants
      • Contact Us
  • Product
    • Korlym for Cushing Syndrome
    • Medical Information Request
    • Patients
  • Research & Pipeline
    • Cortisol Modulation
    • Cortisol Modulation Therapeutic Platform
    • Pipeline and Clinical Trials
    • Publications
    • Investigator-Initiated Studies
    • Compassionate Use
  • Investors
    • Investors Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Careers
    • Benefits
    • Testimonials
    • Current Opportunities
© 2019 Corcept
  • Privacy Policy
  • Terms of Use
  • Site Map